original ) (raw )Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida
M. Saubolle , D. Diekema , N. Legakis
Clinical Microbiology and Infection, 2004
View PDFchevron_right
Fluconazole-resistant Candida in AIDS patients
Deborah Greenspan
Oral Surgery, Oral Medicine, Oral Pathology, 1993
View PDFchevron_right
Inadequacy of fluconazole dosing in patients with candidemia based on Infectious Diseases Society of America (IDSA) guidelines
Katie Suda
Pharmacoepidemiology and Drug Safety, 2007
View PDFchevron_right
Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance
Juan Camarena
Clinical Microbiology and Infection, 2017
View PDFchevron_right
Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?
David Oxman
Journal of Antimicrobial Chemotherapy, 2010
View PDFchevron_right
Evaluation of Susceptibility to Fluconazole and Voriconazole in Oral Candida glabrata Isolates from Drug Addicts
hamid pordeli
International Journal of High Risk Behaviors and Addiction, 2019
View PDFchevron_right
Antibiotic Exposure as a Risk Factor for Fluconazole-Resistant Candida Bloodstream Infection
nathan keller
Antimicrobial Agents and Chemotherapy, 2012
View PDFchevron_right
Distribution of fluconazole-resistant Candida bloodstream isolates among hospitals and inpatient services in Israel
Hila Elinav
Clinical Microbiology and Infection, 2013
View PDFchevron_right
Species distribution and in vitro fluconazole susceptibility of clinical Candida isolates in a Brazilian tertiary-care hospital over a 3-year period
Rosana Serpa
Revista da Sociedade …, 2011
View PDFchevron_right
A Randomized and Blinded Multicenter Trial of High‐Dose Fluconazole plus Placebo versus Fluconazole plus Amphotericin B as Therapy for Candidemia and Its Consequences in Nonneutropenic Subjects
Mitchell Goldman
Clinical Infectious Diseases, 2003
View PDFchevron_right
Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
Patricia Ribaud
Journal of Antimicrobial Chemotherapy, 2006
View PDFchevron_right
Association of clinical and demographic factors in invasive candidiasis caused by fluconazole-resistant Candida species: a study in 15 hospitals, Medellín, Colombia 2010–2011
Jaime Robledo
Diagnostic Microbiology and Infectious Disease, 2014
View PDFchevron_right
Prevalence, susceptibility profile for fluconazole and risk factors for candidemia in a tertiary care hospital in southern Brazil
L. Lunardi
2005
View PDFchevron_right
Association of Fluconazole Pharmacodynamics with Mortality in Patients with Candidemia
Mukesh Patel
Antimicrobial Agents and Chemotherapy, 2008
View PDFchevron_right
Host factors do not influence the colonization or infection by fluconazole resistant Candida species in hospitalized patients
Hsin Chi
Journal of Negative …, 2008
View PDFchevron_right
Direct Fluconazole Disk Susceptibility Testing for Candida glabrata-Positive Blood Cultures
Maya Korem
Journal of Clinical Microbiology, 2021
View PDFchevron_right
Incidence of candidaemia and relationship with fluconazole use in an intensive care unit
Michele Mussap
Journal of Antimicrobial Chemotherapy, 2009
View PDFchevron_right
Multicenter Comparative Evaluation of Six Commercial Systems and the National Committee for Clinical Laboratory Standards M27-A Broth Microdilution Method for Fluconazole Susceptibility Testing of Candida Species
Silvia Covan
Journal of Clinical Microbiology, 2002
View PDFchevron_right
Prospective, Multicenter Surveillance Study of Candida glabrata: Fluconazole and Itraconazole Susceptibility Profiles in Bloodstream, Invasive, and Colonizing Strains and Differences between Isolates from Three Urban Teaching Hospitals in New York City (Candida Susceptibility Trends Study, 1998 t...
David Perlin
Antimicrobial Agents and Chemotherapy, 2002
View PDFchevron_right
Candidaspecies distribution and fluconazole susceptibility of blood isolates at a regional hospital in Passo Fundo, RS, Brazil
Itamar Gonçalves
Jornal Brasileiro de Patologia e Medicina Laboratorial, 2015
View PDFchevron_right
Recovery of fluconazole sensitive Candida ciferrii in a diabetic chronic obstructive pulmonary disease patient presenting with pneumonia
Dr Arnab Maji
Lung India, 2013
View PDFchevron_right
Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS study
Stefan Zimmerli
The Journal of infection, 2018
View PDFchevron_right